. Two distinct surface receptors mediate the effects of 4. TNFa production in the adult heart TNF, TNF receptor 1 (TNFR 1, or p55) and TNFR 2 (p75), with respective M values of 55 000-60 000 and TNFa biosynthesis is largely controlled at the translar 70 000-80 000 in human cells [13] . These receptors are tional level [24] . Moreover, as TNF is efficiently secreted also grouped in a family owing to the presence of from macrophages, immunocytochemical detection of conserved cysteine residues in the N-terminal extracellular these proteins within cells is difficult to assess. To ligand-binding domains [11, 14] . Despite the conserved overcome these limitations, Girior et al. [25] generated extracellular domains, the cytoplasmic domains of the two transgenic mice harbouring the TNFa promoter upstream receptors lack homology, suggesting activation of different of a CAT reporter gene. The CAT enzyme activities were downstream transduction pathways. Both receptor subtypes evident in heart lysates after the mice were exposed to are found in human and rat cardiocytes [15, 16] . TNFR 1 is intraperitoneal lipopolysacharides (LPS). These data sugthe main receptor subtype in most cell types including the gested that TNFa may be secreted by heart cells, while not heart and its complex and divergent downstream signaling excluding the contribution of macrophages in the heart system has been extensively studied. The transduction of lysate assays. To confirm the production of TNFa by signals from TNFR 2 and its role in TNFa signaling intrinsic cardiac cells, primary cardiocytes were extracted remains less well characterized. In the heart, the negative from mice and exposed to LPS in the cell culture environinotropic activity of TNFa appears to be mediated by ment. TNFa levels, measured in the culture media, again activity of the TNFR 1 [15, 16] . Although not characterised demonstrated the increased production of TNFa in the in the heart, the expression of the levels of type 2 receptors presence of LPS [25] . Moreover, using immunohistochin hematopoietic cells can be correlated with sensitivity to emical analysis, TNFa peptide was shown to be produced TNFa-induced apoptosis [13] .
in myocardial cardiocytes, smooth muscle cells and endothelial cells in response to endotoxin in vitro [26] . Following ischaemia, TNFa expression is upregulated in isolated 3. TNFa signalling pathways cardiac myocytes and fibroblasts [27] [28] [29] . Following the onset of experimental myocardial infarction [30] , there is a The binding of TNFa to its cognate homotrimeric diffuse increase in TNFa mRNA expression persisting for receptor results in the formation of multimolecular signal over 1 month. Taken together, these data demonstrate that transduction complexes which can rapidly activate several the heart has an endogenous capacity to produce TNFa in divergent downstream signalling pathways (Fig. 1) . In response to diverse pathophysiological stimuli. brief, the coupling of the adaptor Fas-associated death domain protein (FADD) to TNFR1 is associated with the recruitment and activation of apoptotic proteases with 5. TNFa and cardiac growth subsequent progression to programmed cell death. However, TNFR1 activation is not usually associated with Genetic ablations of TNFa [31] , its cognate receptors apoptosis, due to the induction of a complex cytoprotective (TNFR1 and TNFR2) and of the combined receptors have response that requires TNFR associated factor 2 (TRAF2), been generated in mice. Although not rigorously studied, a signal transducer which couples to TNFR1. This comno obvious defects in cardiac development have been plex activates both NFkB-dependent and -independent described in any of these genetic manipulations. This transcriptional events implicated in the induction of cytosuggests that either the TNF signalling cascade is not protective genes involved in cellular growth, survival and required for normal cardiogenesis or that this pathway is proliferation [17] . Cytoprotective pathways downstream of redundant and compensated for by alternate signalling the TNF receptors that may be relevant to the maintenance pathways. However, in response to pressure-overload and of cardiac homeostasis in response to pressure and volume to isolated stretch, TNFa expression and peptide prooverload were recently reviewed [18] . These include the duction are upregulated in the adult heart [32] , suggesting hypertrophic growth programmes downstream of: protein that in postnatal life this cytokine is directly induced in kinase C (PKC); stress activated protein kinases (SAPK) response to haemodynamic pressure overload. Such a load and downstream of c-Jun N-terminal kinase (JNK). The elicits cardiac myocyte hypertrophy and extracellular putative TNF mediated cardioprotective programmes matrix remodelling. These phenotypic alterations are against ischaemia-reperfusion injury may be downstream thought to be adaptive responses in order to maintain of PKC [19] , NFkB [20] and SAPK [21] . The regulatory normal cardiac contractility and homeostasis in response to balance between these alternate pathways with consequenthe increased workload. In keeping with a possible role of tial propagation of divergent cellular fates (cell survival vs.
TNFa signalling in postnatal cardiac growth, Kapadia et apoptosis) are currently poorly understood and under active al. [32] showed that simple passive stretch of cat papillary investigation. Further details of these pathways have been muscle induced the expression of TNFa mRNA. Physioextensively reviewed [17, 22, 23] and are beyond the scope logically relevant concentrations of TNFa provoke a of this mini-review.
hypertrophic response by increasing the synthesis of both structural and contractile protein in adult feline cardiocytes subjected to an acute infarction in vivo [45] . These data [33] . This response appears to depend on a preserved suggest that TNF signalling, through an unknown mechainteraction between cell integrin and the extracellular nism, is required for endogenous myocardial resistance to matrix [33] . Moreover, Nakamura el al. [34] have sugischaemic cell death. gested that an additional pathway whereby TNFa induces hypertrophy in neonatal rat cardiac myocytes is via activa-6.1. Preconditioning tion of reactive oxygen intermediates.
In a preliminary report, there is further in vivo evidence TNFa may also function as a preconditioning peptide, to support the role of TNFa in the induction of cardiac thereby providing an additional and alternate putative hypertrophy [35] . Transgenic mice overexpressing TNFa mechanism that could confer cardioprotection against specifically in the heart, develop cardiac hypertrophy [36] , myocardial ischaemia-reperfusion injury. Preconditioning these same mice develop myocarditis in response to the agents are by definition extrinsic stimuli which when inflammatory response mediated by TNFa. Interestingly, introduced to the heart prior to an ischaemic insult and the inflammatory response but not the hypertrophic resubsequent reperfusion period, help the heart to be more sponse can be attenuated by genetic attenuation of the resistant to the latter insult. Nelson et al.
[46] demonstrated TNFR1 signalling pathway [35] . In preliminary data we that pretreatment of rabbits with intravenous TNFa 24 h have shown that with the genetic ablation of TNFa, mice before ex vivo simulated ischaemia and reperfusion rehave a significantly reduced right ventricular hypertrophic sulted in improved cardiac contractile functional recovery response to three weeks of hypoxia compared to wild type and reduced lactate dehydrogenase release. These inveslittermate controls (unpublished results).
tigators noted that TNFa pretreatment, with the resultant Taken together, these preliminary data in genetically reduction in ischaemia-reperfusion injury, correlated with modified mice, together with the in vitro data reviewed, an increase in myocardial manganese superoxide dismutase strongly suggest that TNFa binding to its cognate receptor, activity, suggesting a possible mechanism involved in this and the subsequent activation of the downstream signalling cardioprotection. In preliminary data from our laboratory, cascade play a role in the postnatal adaptive myocardial we have pretreated isolated rat hearts with TNFa (0.5 growth response to multiple biomechanical stresses. ng / ml) for 7 min followed by a washout of 10 min prior to a simulated ischaemic-reperfusion protocol. Consistent with the data of Nelson et al.
[46], left ventricular 6. TNFa modulation of cardiac contractile function developed pressure and cardiac contractile functional and its role in myocardial ischaemia recovery markedly increased in the TNFa group compared to vehicle pretreated controls (unpublished results). These In septic shock, experimental evidence links TNFa to data suggest that the known production of TNFa by the reduced cardiac contractility [37] . The putative mechamyocardium in response to an ischaemic and reperfusion nisms for this include: a NO-independent reduction in peak insult [29] , may in fact be an endogenous pathway 21 systolic [Ca ] I [38] ; or a NO-mediated decrease in the activated by the heart to induce short-term intrinsic car- 21 sensitivity of the myofilaments to Ca concentrations dioprotection against subsequent ischaemia-reperfusion [39] . Alternatively, a neutral sphingomyelinase pathway injury. Contrary data were published by Meldrum et al. may be involved [40] . Acute reduction in cardiac contrac- [47] , where they demonstrate that ischaemic preconditiontile function does not, however, necessarily result in long ing or adenosine pretreatment reduces TNFa peptide in the term functional impairment [41] . Theoretically, however, myocardium following a subsequent ischaemic-reperfuchronic TNFa production in the heart may lead to permasion episode. TNFa peptide production by the myocardium nent functional impairment via NO-dependent apoptosis immediately following the preconditioning stimuli was, [42, 43] . Interestingly, myocardial TNFa production has however, not measured and it is hypothetically possible been well documented during acute ischaemia with or that the preconditioning stimuli activates TNFa production without reperfusion [30, 44] . Such myocardial TNFa rewith a resultant autoregulatory negative feedback signal on lease may theoretically reduce cardiac contractility, with subsequent and / or excessive TNFa production. We are subsequent cardioprotection by the attenuation of myocarcurrently investigating TNFa production following classic dial energy demand. Thus, hypothetically, the acute TNFa ischaemic preconditioning stimuli. induced reduction in contractility during acute ischaemic syndromes may be an additional adaptive action of this pleiotropic peptide.
Bifunctional role for TNFa
Further preliminary evidence for a cardioprotective action of TNFa in acute ischaemia is found in mice with 7.1. Arguments from signalling pathways combined genetic ablation of the TNFR1 and TNFR2 receptors. These mice developed larger myocardial inSignalling from the type I TNFa receptor, thought to be farcts, compared to wild-type littermate controls when the more important of the two receptor types in the heart, may lead either to cell survival or to apoptosis [23] . One increased production of TNFa during simulated reperfuproposal is that apoptosis is not the physiological end point sion with adverse effects. Inhibition of the synthesis of for this path, but only results when protein synthesis is TNFa by an inhibitor of p38 MAP kinase decreased blocked [48] . TNFa mediated apoptosis in the heart has production of TNF and improved post-ischaemic function. been described [49] and the regulatory pathways are being Differences from our data include the different means of characterised [50] . The anti-apoptotic pathway is not yet production of ischaemia, the different duration of isfully clarified, but may converge on the activation of the chaemia and the species used. Hypothetically, we induced transcription factor NFkB. The latter promotes the expresmilder ischaemia with less production of TNFa, allowing a sion of cytoprotective genes (described in Section 3 and positive response to added low concentration of TNFa. illustrated in Fig. 1) . Activation of this pathway is thought Moreover, the question which needs to be answered is, to involve the protein factor TRAF-2, that binds directly to whether TNFa's role in inducing an acute reduction of TNFR 2, and indirectly via another protein factor called cardiac contractility is adaptive and confers cardioprotec-TRADD, which binds to the type 1 receptor [48] .
tion or whether it is maladaptive leading to long term The alternate pathway, linked to apoptosis, results in dysfunctional sequelae. activation of caspases, followed by apoptosis. One of the activators of caspase-8 is FADD (Fas-associated death domain protein, also called MORT1 (mediator of receptorinduced toxicity). As expected, in FADD-deficient em-8. Suppression of TNFa release -therapeutic bryonic fibroblasts, stimulation of the TNFR1 did not potentials / pitfalls induce apoptosis [51] . Thus it would be anticipated that FADD-deficient mutant mice would show increased cell
The modulation of inflammatory and apoptotic pathways growth (apoptosis absent or lessened). Unexpectedly, in the heart are thought to be potential therapeutic ap-FADD was required for the development of the ventricular proaches for the treatment of myocarditis, cardiac ismyocardium [51] . Thus, at least in embryogenesis, an chaemia and heart failure [10] . TNFa modulation may be apparently pro-apoptotic path has a role in organogenesis an integral component of both these inflammatory and and in embryonic survival. Therefore, whether the TNFapoptotic programmes, although other therapeutic targets mediated signal results in apoptosis or not may depend on include antagonists to reactive oxygen species, to nitric a complex interaction between the various post-receptor oxide synthase and to angiotensin II production. Treatsignalling pathways, and the exact physiological milieu ments directly targeted at the attenuation of TNFa proinvolved.
duction include: the inhibition of p38 / MAPK signalling pathway in an ex vivo ischaemia-reperfusion model, using 7.2. Concentration-dependent effects SB203580 [55] , and the use of pentoxyfylline in subjects with dilated cardiomyopathy [9] . In the latter pilot randomThe concentration of TNFa interacting with myocardial ized study, Sliwa et al. [9] demonstrated that subjects with cells may also determine its homeostatic effect. In nonidiopathic dilated cardiomyopathy had reduced symptoms, cardiac cultured cells, TNFa-induced apoptosis is conincreased left-ventricular systolic function and reduced centration-dependent, with levels in excess of 0.1 ng / ml plasma TNFa concentrations compared to matching required to produce apoptosis [13] . In neonatal rat venplacebo treated control patients. Additional therapeutic tricular cardiomyocytes, TNFa also has a concentration options for blocking TNF activity have recently been made dependent effect, partially to inhibit the phosphorylation of clinically available and include monoclonal antibodies to phospholamban and of troponin I [52] . Moreover, Franco TNFa, and the recombinant TNF soluble receptor [56] . et al. [53] have demonstrated, using magnetic resonance
The soluble TNFR-fusion protein has been used with imaging and invasive techniques, that the rate and severity reasonable efficacy as an adjuvant agent in the treatment of of TNFa induced left ventricular dysfunction is dependent rheumatoid arthritis [57] . These therapeutic strategies are on the degree of TNFa overexpression in transgenic mice.
currently being evaluated in the treatment of heart failure These data elegantly confirm the earlier observation by and as a potential adjunctive therapy to control TNFa Kubota and colleagues [5, 36] . mediated cardiac cachexia. In a pilot study, Deswal et al. Our preliminary data on the isolated rat heart (unhave demonstrated that the intravenous administration of a published results) show that post-ischaemic recovery of soluble p75 TNF receptor is well tolerated in humans with function is improved by low concentrations of TNFa (0.5 advanced heart failure [58]. In addition, this therapy seems ng / ml). Conversely, Nutt et al. [54] have demonstrated in to: reduce biologically active levels of TNF; enhance the the ex vivo heart that cardiac contractile function is ability of patients to exercise and improves the heart markedly attenuated at higher concentrations of TNFa failure patients perception of quality of life [58] . infusion (i.e. 20 ng / ml). In apparent conflict with our However, these therapies should be viewed in the results, Cain et al. [55] found that severe simulated context of the contrary view initially proposed by Mann ischaemia for 45 min in the human heart resulted in
[8] and expanded on in this review. Our hypothesis states 
Proposed hypothesis for future work
[3] Torre-Amione G, Kapadia S, Lee J et al. Tumor necrosis factor-a and tumor necrosis factor receptors in the failing human heart. Circulation 1996;93:704-711.
In conclusion, we have reviewed data that suggest that heart may play a role in protective cardiac adaptation to myocardial homeostasis is described in Fig. 2 . The molec- further with specific reference to the temporal activity, the 
